CCL2 and inflammatory response: Goeller et al.11 reported that EAT-v was associated with increased TG and decreased HDL, as well as inflammatory biomarkers in plasminogen-activator inhibitor-1 (PAI-1) and monocyte chemoattractant protein-1 (MCP-1), highlighting a complex and multifaceted relationship between EAT, vascular inflammation, and dyslipidaemia.